Search results
Study finds no link between exposure to immunosuppressive therapy, cancer in IBD patients
Medical Xpress· 1 hour agoThere is no significant association between exposure to immunosuppressive therapies and development...
Pasco welcomes new pharmaceutical compounding firm
Tampa Bay Times· 1 day agoPharmacy has opened in the Asturia Corporate Center, part of what Pasco County is calling its “life sciences corridor” in Central Pasco, which will...
Processa reports positive Phase 1b trial results for cancer drug By Investing.com
Investing.com· 6 hours agoProcessa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage pharmaceutical company, has announced...
Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3...
Benzinga· 45 minutes agoLaminar aims to submit regulatory filings or conditional marketing authorization by early 2025. PALMA DE MALLORCA, Spain, June 11, 2024 /CNW/ -- Laminar Pharmaceuticals S.A ...
AstraZeneca finalizes Fusion Pharmaceuticals buyout By Investing.com
Investing.com· 7 days agoThis move is aligned with AstraZeneca (NASDAQ:AZN)'s strategy to advance cancer therapy by focusing...
Ono Pharmaceutical wraps up $2.4 billion Deciphera buyout By Investing.com
Investing.com· 6 hours agoOno Pharmaceutical Co., Ltd. has successfully concluded the acquisition of Deciphera Pharmaceuticals...
...SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop...
Benzinga· 2 hours agoSIPC, a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce a Research and Development ...
Can Chemo Benefit Older Patients With Pancreatic Cancer?
Medscape· 5 days agoBetter tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who...
Woman awarded $260M from Johnson & Johnson following cancer diagnosis
WLBT 3· 4 days agoA woman in Oregon was recently awarded $260 million in a lawsuit against pharmaceutical giant...
Lighthouse Investment Partners LLC Takes $1.13 Million Position in Syndax Pharmaceuticals, Inc....
ETF DAILY NEWS· 11 hours agoLighthouse Investment Partners LLC acquired a new stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) in the 4th quarter, according to its most recent disclosure ...